King Therapeutics LLC research brief
CIK 2088073
Generated Nov. 18, 2026, 2:46 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: PHOENIX Arizona. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 15, 2025 · D · 0002088073-25-000001 · Source evidence
Reported offering amount: 500000 USD. Reported amount sold: 310000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “King Therapeutics LLC research brief,” CIK 2088073, retrieved Nov. 18, 2026, 2:46 a.m.. Cite the specific accessions used. No amounts have been summed.